Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CANSINO-BIOLOGICS-INC-59318312/news/Cansino-Biologics-Inc-Announces-Phase-I-Clinical-Trial-and-Completion-of-First-Patient-Case-for-Rec-45742197/?utm_source=whatsapp&utm_medium=social&utm_campaign=share